ATE101853T1 - Lipidverbindungen abgeleitet von sphingosinen, verfahren zu deren herstellung und verwendung, besonders in der kosmetik und dermopharmazie. - Google Patents

Lipidverbindungen abgeleitet von sphingosinen, verfahren zu deren herstellung und verwendung, besonders in der kosmetik und dermopharmazie.

Info

Publication number
ATE101853T1
ATE101853T1 AT90402577T AT90402577T ATE101853T1 AT E101853 T1 ATE101853 T1 AT E101853T1 AT 90402577 T AT90402577 T AT 90402577T AT 90402577 T AT90402577 T AT 90402577T AT E101853 T1 ATE101853 T1 AT E101853T1
Authority
AT
Austria
Prior art keywords
dermopharmacy
sphingosines
cosmetics
processes
production
Prior art date
Application number
AT90402577T
Other languages
English (en)
Inventor
Alexandre Zysman
Guy Vanlerberghe
Henri Sebag
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE101853T1 publication Critical patent/ATE101853T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT90402577T 1989-09-21 1990-09-19 Lipidverbindungen abgeleitet von sphingosinen, verfahren zu deren herstellung und verwendung, besonders in der kosmetik und dermopharmazie. ATE101853T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8912423A FR2652002B1 (fr) 1989-09-21 1989-09-21 Nouveaux composes lipidiques derives des sphingosines, leur procede de preparation et leurs applications, notamment en cosmetique et en dermopharmacie.
EP90402577A EP0420722B1 (de) 1989-09-21 1990-09-19 Lipidverbindungen abgeleitet von Sphingosinen, Verfahren zu deren Herstellung und Verwendung, besonders in der Kosmetik und Dermopharmazie

Publications (1)

Publication Number Publication Date
ATE101853T1 true ATE101853T1 (de) 1994-03-15

Family

ID=9385738

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90402577T ATE101853T1 (de) 1989-09-21 1990-09-19 Lipidverbindungen abgeleitet von sphingosinen, verfahren zu deren herstellung und verwendung, besonders in der kosmetik und dermopharmazie.

Country Status (7)

Country Link
US (1) US5149860A (de)
EP (1) EP0420722B1 (de)
JP (1) JP2878814B2 (de)
AT (1) ATE101853T1 (de)
CA (1) CA2025790C (de)
DE (1) DE69006811T2 (de)
FR (1) FR2652002B1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0576605A4 (en) * 1991-03-19 1994-06-08 Vithal J Rajadhyaksha Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers
FR2674748B1 (fr) * 1991-04-03 1995-01-13 Oreal Utilisation de sphingolipides dans la preparation d'une composition cosmetique ou dermopharmaceutique protegeant la peau et les cheveux contre les effets nocifs de la pollution atmospherique.
FR2679770A1 (fr) * 1991-08-01 1993-02-05 Oreal Dispersions cationiques pour le traitement des cheveux ou de la peau a base de ceramides et/ou de glycoceramides, compositions cosmetiques les renfermant et leurs applications cosmetiques.
US5679357A (en) * 1991-08-01 1997-10-21 L'oreal Cationic dispersions based on ceramides and/or glycoceramides
GB9124360D0 (en) * 1991-11-15 1992-01-08 Unilever Plc Cosmetic compositions
US5766628A (en) * 1992-02-24 1998-06-16 Merz + Co. Gmbh & Co. Bath and shower composition having vesicle-forming properties and method for the production and use thereof
WO1993020038A1 (en) * 1992-04-03 1993-10-14 Gist-Brocades N.V. Selective n-acylation of amino alcohols
GB9220268D0 (en) * 1992-09-25 1992-11-11 Unilever Plc Cosmetic composition
AU688737B2 (en) * 1992-10-07 1998-03-19 Quest International B.V. Hydroxy alkyl amides of dicarboxylic acids and their use in cosmetic compositions
GB9308103D0 (en) * 1993-04-20 1993-06-02 Unilever Plc Cosmetic composition
ES2152314T3 (es) * 1993-05-06 2001-02-01 Dsm Nv Sintesis enzimatica de ceramidas e hibridos de ceramidas.
EP0716589A4 (de) * 1993-07-23 1997-06-11 Morris Herstein Kosmetische, die hauterneuerung stimulierende zusammensetzung mit langzeit-irritationskontrolle
FR2715933B1 (fr) * 1994-02-07 1996-04-12 Oreal Nouveaux N-(hydroxyalkyl) carbamates d'alkyle et leurs applications en cosmétique, plus particulièrement dans des compositions capillaires.
FR2718641B1 (fr) * 1994-04-13 1996-05-15 Oreal Composition cosmétique contenant un agent hydratant.
EP0688871A3 (de) 1994-06-24 1998-07-08 Quest International B.V. Herstellung von Phytosphingosin-Derivaten
FR2725131B1 (fr) * 1994-09-29 1996-10-31 Oreal Utilisation de n-(hydroxyalkyl)carbamates d'alkyle dans une composition cosmetique
US5635536A (en) * 1994-12-07 1997-06-03 Pharmacia & Upjohn Aktiebolag Emulsion suitable for administering a sphingolipid
US5500451A (en) * 1995-01-10 1996-03-19 The Procter & Gamble Company Use of polyglycerol aliphatic ether emulsifiers in making high internal phase emulsions that can be polymerized to provide absorbent foams
FR2730410B1 (fr) * 1995-02-15 1997-03-21 Oreal Composition cosmetique comprenant une association de ceramides et son utilisation
US5582832A (en) * 1995-06-06 1996-12-10 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Compositions for topical application to skin
FR2750046B1 (fr) * 1996-06-19 1998-09-04 Oreal Compositions sous forme d'un gel aqueux comprenant un ceramide ou un compose de type ceramide
GB9614889D0 (en) * 1996-07-16 1996-09-04 John P Robarts Research Inst T Ceramide promoters of haematopoiesis
DE19643585A1 (de) * 1996-10-22 1998-04-23 Beiersdorf Ag Antiadhäsive Sphingolipide
DE69819443T2 (de) * 1997-05-02 2004-11-04 Cosmoferm B.V. Antimikrobielle mittel zur topische verwendung
FR2770523B1 (fr) * 1997-11-04 1999-12-31 Oreal Compose de type ceramide, procede de preparation et utilisation
FR2775977B1 (fr) * 1998-03-10 2000-06-23 Oreal Composes lipidiques derives des bases sphingoides, leur procede de preparation et leurs utilisations en cosmetique et en dermopharmacie
DE10013796A1 (de) * 2000-03-20 2001-09-27 Kaercher Gmbh & Co Alfred Dekontaminations-Zusammensetzung sowie Emulsionen hieraus
US7169382B2 (en) * 2003-01-30 2007-01-30 L'oreal Reconstructed epidermis/skin equivalent comprising a ceramide 7 and /or 5.5 and lipid lamellar vesicular compositions comprising ceramide 7 and/or 5.5 compounds
FR2850570B1 (fr) * 2003-01-30 2005-03-11 Oreal Composition a base de vesicules lamellaires lipidiques incorporant au moins un derive de la famille du ceramide 7 et/ou 5.5, utilisation pour ameliorer la fonction barriere des epidermes
EP2174646B1 (de) * 2007-08-09 2019-05-22 Kao Corporation Umgedrehtes vesikel
GB0910723D0 (en) * 2009-06-22 2009-08-05 Sylentis Sau Novel drugs for inhibition of gene expression
JP5647786B2 (ja) * 2009-12-28 2015-01-07 花王株式会社 油性組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU546872B2 (en) * 1982-06-16 1985-09-26 Unilever Plc Skin treatment compositions containing a fatty acid or ester
US4737518A (en) * 1984-04-03 1988-04-12 Takeda Chemical Industries, Ltd. Lipid derivatives, their production and use

Also Published As

Publication number Publication date
FR2652002A1 (fr) 1991-03-22
FR2652002B1 (fr) 1991-11-29
US5149860A (en) 1992-09-22
EP0420722B1 (de) 1994-02-23
DE69006811D1 (de) 1994-03-31
JPH03193754A (ja) 1991-08-23
DE69006811T2 (de) 1994-06-01
EP0420722A2 (de) 1991-04-03
CA2025790C (fr) 2000-01-04
EP0420722A3 (en) 1991-05-15
JP2878814B2 (ja) 1999-04-05
CA2025790A1 (fr) 1991-03-22

Similar Documents

Publication Publication Date Title
ATE101853T1 (de) Lipidverbindungen abgeleitet von sphingosinen, verfahren zu deren herstellung und verwendung, besonders in der kosmetik und dermopharmazie.
ES2074835T3 (es) Ceramidas, su procedimiento de preparacion y sus aplicaciones en cosmetica y en dermofarmacia.
IL109848A0 (en) Vitamin d compounds, their preparation and pharmaceutical and cosmetic compositions containing them
DE68905170D1 (de) Akyloxyalkylierte polyorganosiloxane enthaltende rasierzusammensetzung fuer die haut und verfahren zu ihrer herstellung.
AU548974B2 (en) Oligoglucoside derivatives
CA2032355A1 (fr) Procede de preparation de (meth)acrylate d'alkylimidazolidone
FI894061A0 (fi) Menetelmä lääkeaineina käyttökelpoisten , -disubstituoitujen N-sykloalkyylialkyylibentsyyliamiinien valmistamiseksi ja niiden synteesivälituotteita
NZ228065A (en) 1,2,4-triazinediones and parasiticidal compositions; processes for preparation
PT71773B (de) Verfahren zur herstellung von substituierten oxirancarbonsauren
ES548357A0 (es) Procedimiento para preparar derivados de n-(adamantil-1)-pirrolidon-5-carboxamida-2.
BR8803402A (pt) Poliisocianatos aromaticos,processo para a sua preparacao e utilizacao
NO873564L (no) Nye tyroninderivater.
ATE215934T1 (de) Neue histidinderivate, verfahren zu ihrer herstellung und ihre verwendung als mittel gegen freie radikale
ATE82747T1 (de) Verfahren zur herstellung von hydroxyalkylierungsmitteln, die erhaltenen mittel und deren verwendung.
DE69316324D1 (de) 4-Hydroxy-phenyl-beta-D-glukose-monoester, Verfahren zur ihrer Herstellung und ihre Verwendung in der Kosmetik, der Pharmazie, als Zahnpflegemitteln und Lebensmitteln
PT79724A (en) Chemical synthesis
JPS52100470A (en) Synthesis of hydantoin derivatives
ATE57T1 (de) 4,5-methano-bufadienolid-rhamnoside, verfahren zu deren herstellung und diese enthaltende arzneimittel.
AU618895B2 (en) Polycarboxylic acid imidazolines, process for the preparation thereof and cleaning agents containing them
CA2027542A1 (en) Uv-absorbing cyclic enaminoketones
ATE15898T1 (de) Neue n-substitierte polyglycidylurazolverbindungen, verfahren zu ihrer herstellung sowie pharmazeutische zubereitungen.
ES480969A1 (es) Procedimiento para la aclaracion optica de materiales organicos, en especial de tipo textil.
DE59607280D1 (de) Verwendung von aminoalkoholderivaten als arzneimittel, derivate sowie verfahren zu deren herstellung
ATE27955T1 (de) Verfahren und zwischenprodukte zur herstellung von 2-substituierten 4-acetyl-imidazolen.
ATE12238T1 (de) Neue ketale von 3'''-dehydro-cardenolidtridigitoxosiden, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties